A Phase 4, Open-Label Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole
Phase of Trial: Phase IV
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Sponsors Takeda
- 21 Jul 2016 Status changed from active, no longer recruiting to completed.
- 29 Apr 2016 Planned End Date changed from 1 Nov 2015 to 1 Jul 2016.
- 29 Apr 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Jun 2016.